Carisma Therapeutics (CARM) Competitors $0.20 -0.02 (-7.64%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$0.21 +0.01 (+7.11%) As of 04/15/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CARM vs. SRZN, KZR, SCYX, COEP, OSTX, ALGS, ESLA, NRXP, MRNS, and LTRNShould you be buying Carisma Therapeutics stock or one of its competitors? The main competitors of Carisma Therapeutics include Surrozen (SRZN), Kezar Life Sciences (KZR), SCYNEXIS (SCYX), Coeptis Therapeutics (COEP), OS Therapies (OSTX), Aligos Therapeutics (ALGS), Estrella Immunopharma (ESLA), NRx Pharmaceuticals (NRXP), Marinus Pharmaceuticals (MRNS), and Lantern Pharma (LTRN). These companies are all part of the "pharmaceutical products" industry. Carisma Therapeutics vs. Surrozen Kezar Life Sciences SCYNEXIS Coeptis Therapeutics OS Therapies Aligos Therapeutics Estrella Immunopharma NRx Pharmaceuticals Marinus Pharmaceuticals Lantern Pharma Surrozen (NASDAQ:SRZN) and Carisma Therapeutics (NASDAQ:CARM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Does the MarketBeat Community favor SRZN or CARM? Carisma Therapeutics received 12 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 78.26% of users gave Carisma Therapeutics an outperform vote while only 28.57% of users gave Surrozen an outperform vote. CompanyUnderperformOutperformSurrozenOutperform Votes628.57% Underperform Votes1571.43% Carisma TherapeuticsOutperform Votes1878.26% Underperform Votes521.74% Which has more risk and volatility, SRZN or CARM? Surrozen has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Carisma Therapeutics has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Is SRZN or CARM more profitable? Surrozen has a net margin of 0.00% compared to Carisma Therapeutics' net margin of -314.78%. Surrozen's return on equity of -120.51% beat Carisma Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -120.51% -54.68% Carisma Therapeutics -314.78%-957.20%-96.39% Which has stronger earnings & valuation, SRZN or CARM? Surrozen has higher earnings, but lower revenue than Carisma Therapeutics. Surrozen is trading at a lower price-to-earnings ratio than Carisma Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$10.66M3.00-$43.04M-$21.77-0.45Carisma Therapeutics$19.63M0.42-$86.88M-$1.56-0.13 Do analysts rate SRZN or CARM? Surrozen currently has a consensus target price of $38.50, indicating a potential upside of 294.87%. Carisma Therapeutics has a consensus target price of $1.93, indicating a potential upside of 877.16%. Given Carisma Therapeutics' higher probable upside, analysts plainly believe Carisma Therapeutics is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Carisma Therapeutics 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.43 Do institutionals & insiders have more ownership in SRZN or CARM? 66.6% of Surrozen shares are held by institutional investors. Comparatively, 44.3% of Carisma Therapeutics shares are held by institutional investors. 43.5% of Surrozen shares are held by insiders. Comparatively, 12.6% of Carisma Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to SRZN or CARM? In the previous week, Surrozen had 1 more articles in the media than Carisma Therapeutics. MarketBeat recorded 3 mentions for Surrozen and 2 mentions for Carisma Therapeutics. Surrozen's average media sentiment score of 0.98 beat Carisma Therapeutics' score of 0.89 indicating that Surrozen is being referred to more favorably in the media. Company Overall Sentiment Surrozen Positive Carisma Therapeutics Positive SummarySurrozen beats Carisma Therapeutics on 11 of the 19 factors compared between the two stocks. Remove Ads Get Carisma Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CARM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CARM vs. The Competition Export to ExcelMetricCarisma TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.23M$6.33B$5.33B$7.57BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-0.136.7921.7317.81Price / Sales0.42225.96379.2094.61Price / CashN/A65.6738.1534.64Price / Book0.305.866.464.00Net Income-$86.88M$141.86M$3.20B$247.23M7 Day Performance-0.35%4.50%2.85%1.45%1 Month Performance-52.07%-12.65%-8.55%-6.24%1 Year Performance-88.41%-11.06%10.46%0.60% Carisma Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CARMCarisma Therapeutics2.4853 of 5 stars$0.20-7.6%$1.93+877.2%-88.8%$8.23M$19.63M-0.1320Gap UpSRZNSurrozen3.5888 of 5 stars$9.80-10.8%$38.50+292.9%+0.0%$31.85M$10.66M-0.4580Short Interest ↓Gap UpKZRKezar Life Sciences4.2464 of 5 stars$4.35+5.6%$39.50+808.0%-49.2%$31.78M$7M-0.3360SCYXSCYNEXIS0.4191 of 5 stars$0.81-3.7%N/A-37.7%$31.52M$3.75M-1.0960Gap UpCOEPCoeptis Therapeutics0.5947 of 5 stars$9.25-4.3%N/A+26.8%$31.13MN/A-1.592Short Interest ↑OSTXOS Therapies2.0348 of 5 stars$1.43+2.1%$18.00+1,158.7%N/A$30.98MN/A0.00N/AALGSAligos Therapeutics4.0404 of 5 stars$5.05-15.1%$70.00+1,286.1%-78.9%$30.88M$3.95M-0.3890Positive NewsHigh Trading VolumeESLAEstrella Immunopharma2.8263 of 5 stars$0.85-3.4%$16.00+1,782.4%-19.7%$30.74MN/A-3.27N/AShort Interest ↓Positive NewsNRXPNRx Pharmaceuticals2.036 of 5 stars$1.81+1.1%$28.25+1,460.8%-59.8%$30.62MN/A-0.852Short Interest ↑MRNSMarinus Pharmaceuticals2.0745 of 5 stars$0.55-0.2%$4.79+771.6%-57.8%$30.32M$30.99M-0.22110LTRNLantern Pharma2.1995 of 5 stars$2.81-6.0%$25.00+789.7%-41.0%$30.31MN/A-1.5820Positive News Remove Ads Related Companies and Tools Related Companies Surrozen Alternatives Kezar Life Sciences Alternatives SCYNEXIS Alternatives Coeptis Therapeutics Alternatives OS Therapies Alternatives Aligos Therapeutics Alternatives Estrella Immunopharma Alternatives NRx Pharmaceuticals Alternatives Marinus Pharmaceuticals Alternatives Lantern Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CARM) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carisma Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carisma Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CARM Stock Free CARM Stock Alerts